Medicine

The at-home nasal swab kit simultaneously tests for COVID-19 and two strains of the flu.

Will Senator John Fetterman's openness about his depression help remove some of the stigma around mental illness?

For a product whose toxic origins trace back to a biological weapons lab in Maryland, Botox has helped normalize cosmetic injectables

A new microneedling technique utilizes a solution based on human stem cells to increase the treatment’s effect. WHYY’s host of The Pulse, Maiken Scott, gave it a try.

Demand for COVID-19 vaccines has faded, but local health workers are trying to get more people up-to-date with their immunization.

Experts say depression occurs after a stroke in about 1 in 3 patients. There may be a biological reason, with some evidence suggesting that strokes might cause brain changes.

Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. But the price tag could prove to be a barrier for many.

The four-hour celebration aims to raise awareness and money to support research into neurofibromatosis and childhood tumors.

The College of Physicians of Philadelphia and Penn’s Perelman School of Medicine are hoping to influence more young, Black men to enter med school.

Medical students at the University of Pennsylvania can take a class that teaches major public health issues, and prepares them for patient advocacy.

Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May.

With only one FDA approved topical cream for vitiligo — finding comfort in one’s own skin comes at a cost.

Dr. Lisa Fitzpatrick believes plainspoken information from trusted messengers can help shrink health disparities, and some insurers are buying in.

U.S. health officials said Thursday a company is recalling its over-the-counter eye drops that have been linked to an outbreak of drug-resistant infections.

Getting an ADHD diagnosis and treatment from online platforms like Cerebral and Done seemed to increase demand for the stimulant Adderall - but that’s just part of the problem